simvastatin has been researched along with Ventricular Dysfunction, Left in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 10 (55.56) | 29.6817 |
| 2010's | 6 (33.33) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Haczkiewicz-Leśniak, K; Kwiatkowska, J; Piasecki, T; Podhorska-Okołów, M; Sapa-Wojciechowska, A; Skrzypiec-Spring, M; Szeląg, A | 1 |
| Adams, ME; Bible, KL; Froehner, SC; Kim, MJ; Regnier, M; Whitehead, NP | 1 |
| Huang, XH; Hui, RT; Liu, G; Lu, J; Xu, YL; Zheng, XX | 1 |
| Chai, CY; Chen, IC; Chen, IJ; Chou, SH; Dai, ZK; Tan, MS; Wu, BN; Yeh, JL | 1 |
| Cioffi, G; Cramariuc, D; Devereux, RB; Gerdts, E; Ray, S; Rieck, AE; Staal, EM; Wachtell, K | 1 |
| Dumesnil, JG; Pibarot, P | 1 |
| Adachi, S; Hirao, K; Isobe, M; Ito, H; Maejima, Y; Nobori, K; Ono, Y; Suzuki, J | 1 |
| Boman, K; Devereux, RB; Egstrup, K; Gohlke-Baerwolf, C; Greve, AM; Kesäniemi, YA; Køber, L; Nienaber, C; Ray, S; Rossebø, AB; Wachtell, K; Willenheimer, R | 1 |
| Armendaris, MK; Beck, AL; D'Avila, LB; Netto, FM; Otto, ME; Sposito, AC | 1 |
| Iqbal, P; Jamil, S | 1 |
| Bonow, RO; Gheorghiade, M; Kim, RJ; Klein, L; Stone, NJ | 1 |
| Ahn, YK; Cho, JG; Hong, SN; Hong, YJ; Hur, SH; Hyun, DW; Jeong, MH; Kang, DG; Kang, JC; Kim, JH; Kim, KB; Kim, KH; Kim, W; Lee, SH; Lee, YS; Lim, SY; Park, HW; Park, JC; Yun, KH | 1 |
| Elrod, JW; Greer, JJ; Jones, SP; Kakkar, AK; Lefer, DJ; Watson, LJ | 1 |
| Ahn, Y; Cho, JG; Hong, SN; Hong, YJ; Hwang, SH; Jeong, MH; Kang, JC; Kim, JH; Kim, KH; Lee, SR; Park, HW; Park, JC; Yun, NS | 1 |
| Bauersachs, J; Fraccarollo, D; Hiss, K; Laufs, U; Ruetten, H | 1 |
| Bartuś, S; Bryniarski, L; Dobrowolski, W; Dudek, D; Giszterowicz, D; Korpak-Wysocka, R; Kukla, P | 1 |
| Belichard, P; Bontemps, L; de Lorgeril, M; Geyssant, A; Itti, R; Salen, P | 1 |
| Jones, SP; Lefer, DJ; Trocha, SD | 1 |
1 review(s) available for simvastatin and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Effects of lipophilic statins for heart failure: a meta-analysis of 13 randomised controlled trials.
Topics: Atorvastatin; Cholesterol, LDL; Disease Progression; Heart Failure; Heptanoic Acids; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles; Quinolines; Randomized Controlled Trials as Topic; Simvastatin; Stroke Volume; Ventricular Dysfunction, Left | 2014 |
5 trial(s) available for simvastatin and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Low-flow aortic stenosis in asymptomatic patients: valvular-arterial impedance and systolic function from the SEAS Substudy.
Topics: Aged; Aged, 80 and over; Aortic Valve Stenosis; Atherosclerosis; Azetidines; Disease Progression; Double-Blind Method; Drug Combinations; Echocardiography, Doppler; Europe; Ezetimibe, Simvastatin Drug Combination; Female; Hemodynamics; Humans; Hypolipidemic Agents; Logistic Models; Male; Middle Aged; Myocardial Contraction; Predictive Value of Tests; Prospective Studies; Risk Assessment; Risk Factors; ROC Curve; Sensitivity and Specificity; Simvastatin; Systole; Treatment Outcome; United States; Ventricular Dysfunction, Left | 2009 |
Synergistic effect of combined HMG-CoA reductase inhibitor and angiotensin-II receptor blocker therapy in patients with chronic heart failure: the HF-COSTAR trial.
Topics: Aged; Angiotensin Receptor Antagonists; Chronic Disease; Drug Synergism; Drug Therapy, Combination; Electrocardiography; Female; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Losartan; Male; Middle Aged; Prospective Studies; Renin-Angiotensin System; Simvastatin; Treatment Outcome; Ventricular Dysfunction, Left | 2011 |
Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
Topics: Aged; Aged, 80 and over; Aortic Valve Stenosis; Azetidines; Cardiovascular Diseases; Drug Therapy, Combination; Electrocardiography; Ezetimibe; Female; Follow-Up Studies; Heart Failure; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardial Infarction; Prognosis; Simvastatin; Ventricular Dysfunction, Left | 2012 |
Diastolic function parameters are improved by the addition of simvastatin to enalapril-based treatment in hypertensive individuals.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomarkers; Blood Pressure; Brazil; Chi-Square Distribution; Cholesterol; Diastole; Diuretics; Double-Blind Method; Drug Therapy, Combination; Echocardiography, Doppler; Enalapril; Female; Humans; Hydrochlorothiazide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Male; Middle Aged; Prospective Studies; Regression Analysis; Simvastatin; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2012 |
Effects of lipid-lowering drugs on left ventricular function and exercise tolerance in dyslipidemic coronary patients.
Topics: Blood Pressure; Cholesterol, LDL; Coronary Disease; Double-Blind Method; Dyspepsia; Exercise Test; Female; Fenofibrate; Fibrinogen; Heart Rate; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Patient Dropouts; Physical Endurance; Simvastatin; Stroke Volume; Treatment Outcome; Triglycerides; Ventricular Dysfunction, Left; Ventricular Function, Left | 1999 |
12 other study(ies) available for simvastatin and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
HMG-CoA Reductase Inhibitor, Simvastatin Is Effective in Decreasing Degree of Myocarditis by Inhibiting Metalloproteinases Activation.
Topics: Animals; Autoimmune Diseases; Cardiotonic Agents; Echocardiography; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Metalloproteases; Models, Animal; Myocarditis; Rats; Simvastatin; Ventricular Dysfunction, Left | 2021 |
Simvastatin provides long-term improvement of left ventricular function and prevents cardiac fibrosis in muscular dystrophy.
Topics: Animals; Autonomic Nervous System; Calcium-Binding Proteins; Cardiomyopathies; Disease Models, Animal; Fibrosis; Heart; Heart Rate; Male; Mice, Inbred mdx; Muscular Dystrophy, Duchenne; Myocytes, Cardiac; Phosphorylation; Recovery of Function; Simvastatin; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2019 |
Statins ameliorate pulmonary hypertension secondary to left ventricular dysfunction through the Rho-kinase pathway and NADPH oxidase.
Topics: Animals; Disease Models, Animal; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Male; NADPH Oxidases; Rats; Rats, Wistar; Reactive Oxygen Species; rho-Associated Kinases; Simvastatin; Ventricular Dysfunction, Left | 2017 |
Aortic stenosis: look globally, think globally.
Topics: Aortic Valve Stenosis; Atherosclerosis; Azetidines; Calcinosis; Disease Progression; Drug Combinations; Echocardiography, Doppler; Ezetimibe, Simvastatin Drug Combination; Hemodynamics; Humans; Hypolipidemic Agents; Myocardial Contraction; Predictive Value of Tests; Risk Assessment; Risk Factors; Simvastatin; Systole; Treatment Outcome; Ventricular Dysfunction, Left | 2009 |
Rhabdomyolysis induced by a single dose of a statin.
Topics: Dyspnea; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Male; Middle Aged; Rhabdomyolysis; Simvastatin; Ventricular Dysfunction, Left | 2004 |
Improvement in the function of hibernating myocardium in a patient with heart failure due to coronary artery disease receiving high-dose simvastatin.
Topics: Aged; Coronary Angiography; Coronary Artery Disease; Dose-Response Relationship, Drug; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Magnetic Resonance Imaging; Male; Myocardial Contraction; Myocardial Stunning; Simvastatin; Stroke Volume; Ventricular Dysfunction, Left | 2004 |
Prognostic significance of simvastatin therapy in patients with ischemic heart failure who underwent percutaneous coronary intervention for acute myocardial infarction.
Topics: Aged; Angioplasty, Balloon, Coronary; C-Reactive Protein; Coronary Angiography; Female; Fibrinogen; Humans; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Prognosis; Prospective Studies; Simvastatin; Survival Rate; Treatment Outcome; Ventricular Dysfunction, Left | 2005 |
Low-dose simvastatin improves survival and ventricular function via eNOS in congestive heart failure.
Topics: Animals; Gene Expression Regulation, Enzymologic; Heart Failure; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Lipids; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocardial Infarction; Nitric Oxide Synthase Type III; Pulmonary Edema; Severity of Illness Index; Simvastatin; Survival Rate; Ventricular Dysfunction, Left | 2006 |
Effect of combination therapy with simvastatin and carvedilol in patients with left ventricular dysfunction complicated with acute myocardial infarction who underwent percutaneous coronary intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Carbazoles; Carvedilol; Death; Disease-Free Survival; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Infarction; Propanolamines; Retrospective Studies; Simvastatin; Stroke Volume; Treatment Outcome; Ventricular Dysfunction, Left | 2006 |
Simvastatin improves left ventricular function after myocardial infarction in hypercholesterolemic rabbits by anti-inflammatory effects.
Topics: Animals; Anti-Inflammatory Agents; Biomarkers; C-Reactive Protein; Diet; Echocardiography; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Models, Animal; Myocardial Infarction; Nitric Oxide Synthase Type III; Rabbits; rac1 GTP-Binding Protein; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Simvastatin; Ventricular Dysfunction, Left | 2006 |
[Transient left ventricular apical ballooning syndrome--a case report].
Topics: Aged; Amlodipine; Echocardiography, Doppler; Electrocardiography; Enoxaparin; Female; Humans; Simvastatin; Syndrome; Treatment Outcome; Ventricular Dysfunction, Left | 2007 |
Pretreatment with simvastatin attenuates myocardial dysfunction after ischemia and chronic reperfusion.
Topics: Animals; Anticholesteremic Agents; Hemodynamics; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Premedication; Simvastatin; Ultrasonography; Ventricular Dysfunction, Left | 2001 |